IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
0.8146
-0.0099 (-1.20%)
At close: Oct 16, 2026, 4:00 PM EDT
0.8165
+0.0019 (0.23%)
Pre-market: Oct 19, 2026, 7:00 AM EDT
IRIDEX Revenue
IRIDEX had revenue of $12.57M in the quarter ending July 4, 2026, a decrease of -7.41%. This brings the company's revenue in the last twelve months to $51.57M, up 3.68% year-over-year. In the fiscal year ending January 3, 2026, IRIDEX had annual revenue of $52.68M with 8.23% growth. That makes IRIDEX the 27,749th largest company in the world by revenue and 3,764th in the United States.
Revenue (ttm)
$51.57M
Revenue Growth
+3.68%
P/S Ratio
0.28
Revenue / Employee
$554,548
Employees
93
Market Cap
14.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 3, 2026 | 52.68M | 4.01M | 8.23% |
| Dec 28, 2024 | 48.67M | -3.20M | -6.17% |
| Dec 30, 2023 | 51.87M | -5.10M | -8.96% |
| Dec 31, 2022 | 56.97M | 3.07M | 5.69% |
| Jan 1, 2022 | 53.90M | 17.56M | 48.30% |
| Jan 2, 2021 | 36.35M | -7.10M | -16.34% |
| Dec 28, 2019 | 43.45M | 847.00K | 1.99% |
| Dec 29, 2018 | 42.60M | 1.01M | 2.42% |
| Dec 30, 2017 | 41.59M | -4.57M | -9.89% |
| Dec 31, 2016 | 46.16M | 4.40M | 10.54% |
| Jan 2, 2016 | 41.76M | -1.06M | -2.47% |
| Jan 3, 2015 | 42.81M | 4.54M | 11.86% |
| Dec 28, 2013 | 38.27M | 4.41M | 13.04% |
| Dec 29, 2012 | 33.86M | 700.00K | 2.11% |
| Dec 31, 2011 | 33.16M | 851.00K | 2.63% |
| Jan 1, 2011 | 32.31M | 1.28M | 4.11% |
| Jan 2, 2010 | 31.03M | - | - |
| Jan 3, 2009 | - | - | - |
| Dec 29, 2007 | - | - | - |
| Dec 30, 2006 | 35.90M | -1.13M | -3.04% |
| Dec 31, 2005 | 37.03M | 4.22M | 12.86% |
| Jan 1, 2005 | 32.81M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Cytosorbents | 37.22M |
| Baird Medical Investment Holdings | 24.49M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| InspireMD | 10.84M |
| Sintx Technologies | 1.33M |
IRIX News
- 7 days ago - Iridex publishes two-year MicroPulse Technology clinical study data - TheFly
- 14 days ago - Iridex Completes Relocation of Manufacturing Facility to San Jose, California - GlobeNewsWire
- 2 months ago - IRIDEX Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - IRIDEX Earnings release: Q2 2026 - Filings
- 2 months ago - IRIDEX Quarterly report: Q2 2026 - Filings
- 2 months ago - Iridex Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 - GlobeNewsWire
- 3 months ago - Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering - GlobeNewsWire